Masimo Gross Margin 2010-2024 | MASI

Current and historical gross margin for Masimo (MASI) over the last 10 years. The current gross profit margin for Masimo as of March 31, 2024 is %.
Masimo Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-03-31 $1.98B $0.96B 48.63%
2023-12-31 $2.05B $1.00B 49.02%
2023-09-30 $2.12B $1.05B 49.81%
2023-06-30 $2.19B $1.10B 50.41%
2023-03-31 $2.30B $1.14B 49.61%
2022-12-31 $2.04B $1.06B 52.04%
2022-09-30 $1.75B $0.96B 55.04%
2022-06-30 $1.50B $0.88B 58.64%
2022-03-31 $1.24B $0.82B 65.68%
2021-12-31 $1.24B $0.81B 65.29%
2021-09-30 $1.21B $0.78B 64.76%
2021-06-30 $1.18B $0.76B 64.23%
2021-03-31 $1.17B $0.76B 64.36%
2020-12-31 $1.14B $0.74B 65.03%
2020-09-30 $1.10B $0.72B 66.00%
2020-06-30 $1.05B $0.70B 66.89%
2020-03-31 $0.98B $0.66B 67.86%
2019-12-31 $0.94B $0.63B 66.99%
2019-09-30 $0.91B $0.61B 66.74%
2019-06-30 $0.90B $0.60B 66.41%
2019-03-31 $0.88B $0.58B 66.40%
2018-12-31 $0.86B $0.58B 66.94%
2018-09-30 $0.84B $0.57B 67.06%
2018-06-30 $0.83B $0.55B 66.46%
2018-03-31 $0.81B $0.53B 66.25%
2017-12-31 $0.79B $0.52B 66.08%
2017-09-30 $0.78B $0.52B 66.67%
2017-06-30 $0.76B $0.51B 67.02%
2017-03-31 $0.74B $0.50B 67.12%
2016-12-31 $0.71B $0.48B 67.04%
2016-09-30 $0.68B $0.44B 64.95%
2016-06-30 $0.66B $0.43B 65.21%
2016-03-31 $0.65B $0.42B 65.07%
2015-12-31 $0.63B $0.41B 64.98%
2015-09-30 $0.63B $0.42B 66.61%
2015-06-30 $0.62B $0.41B 66.61%
2015-03-31 $0.60B $0.40B 66.61%
2014-12-31 $0.59B $0.39B 66.44%
2014-09-30 $0.57B $0.37B 65.61%
2014-06-30 $0.55B $0.36B 65.52%
2014-03-31 $0.55B $0.36B 65.64%
2013-12-31 $0.55B $0.36B 65.75%
2013-09-30 $0.54B $0.36B 66.23%
2013-06-30 $0.52B $0.35B 66.03%
2013-03-31 $0.51B $0.34B 65.88%
2012-12-31 $0.49B $0.33B 65.92%
2012-09-30 $0.47B $0.31B 65.96%
2012-06-30 $0.46B $0.30B 65.94%
2012-03-31 $0.45B $0.30B 66.52%
2011-12-31 $0.44B $0.29B 66.97%
2011-09-30 $0.43B $0.29B 67.90%
2011-06-30 $0.43B $0.30B 69.30%
2011-03-31 $0.42B $0.29B 69.76%
2010-12-31 $0.41B $0.29B 70.44%
2010-09-30 $0.39B $0.28B 70.74%
2010-06-30 $0.38B $0.27B 70.71%
2010-03-31 $0.36B $0.26B 71.07%
2009-12-31 $0.35B $0.25B 71.35%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.678B $2.048B
Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $203.970B 24.72
Intuitive Surgical (ISRG) United States $161.392B 91.55
Edwards Lifesciences (EW) United States $52.125B 33.92
DexCom (DXCM) United States $44.405B 67.27
Alcon (ALC) Switzerland $44.397B 31.81
IQVIA Holdings (IQV) United States $40.917B 23.74
IDEXX Laboratories (IDXX) United States $38.667B 45.32
STERIS (STE) Ireland $22.172B 25.90
Hologic (HOLX) United States $18.229B 20.39
Waters (WAT) United States $17.957B 26.39
SONOVA HOLDING (SONVY) Switzerland $17.634B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $11.555B 13.49
Teleflex (TFX) United States $10.447B 16.26
Sysmex ADR (SSMXY) Japan $10.171B 31.89
Globus Medical (GMED) United States $9.832B 28.82
Penumbra (PEN) United States $7.360B 83.64
Glaukos (GKOS) United States $6.081B 0.00
TransMedics (TMDX) United States $4.848B 460.00
Integer Holdings (ITGR) United States $4.225B 25.53
PROCEPT BioRobotics (PRCT) United States $3.470B 0.00
Inari Medical (NARI) United States $3.192B 0.00
LivaNova (LIVN) United Kingdom $2.865B 17.01
Tandem Diabetes Care (TNDM) United States $2.820B 0.00
Integra LifeSciences Holdings (IART) United States $2.470B 10.77
Veracyte (VCYT) United States $1.772B 0.00
RxSight (RXST) United States $1.730B 0.00
Alphatec Holdings (ATEC) United States $1.551B 0.00
Artivion (AORT) United States $1.135B 108.88
Silk Road Medical (SILK) United States $1.068B 0.00
OPKO Health (OPK) United States $1.039B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.009B 19.63
Pulse Biosciences (PLSE) United States $0.977B 0.00
OrthoPediatrics (KIDS) United States $0.776B 0.00
SiBone (SIBN) United States $0.684B 0.00
Paragon 28 (FNA) United States $0.672B 0.00
Mesa Laboratories (MLAB) United States $0.585B 17.30
ORTHOFIX MEDICAL INC (OFIX) United States $0.580B 0.00
IRadimed (IRMD) United States $0.572B 32.06
Treace Medical Concepts (TMCI) United States $0.489B 0.00
Pacific Biosciences Of California (PACB) United States $0.452B 0.00
AxoGen (AXGN) United States $0.399B 0.00
Sight Sciences (SGHT) United States $0.379B 0.00
Nevro (NVRO) United States $0.334B 0.00
Tactile Systems Technology (TCMD) United States $0.294B 10.07
AngioDynamics (ANGO) United States $0.288B 0.00
Semler Scientific (SMLR) United States $0.237B 12.02
NeuroPace (NPCE) United States $0.229B 0.00
Delcath Systems (DCTH) United States $0.229B 0.00
Inogen (INGN) United States $0.218B 0.00
CVRx (CVRX) United States $0.202B 0.00
ClearPoint Neuro (CLPT) United States $0.194B 0.00
EDAP TMS S.A (EDAP) France $0.189B 0.00
908 Devices (MASS) United States $0.186B 0.00
Accuray (ARAY) United States $0.179B 0.00
Atossa Genetics (ATOS) United States $0.169B 0.00
Alpha Tau Medical (DRTS) Israel $0.146B 0.00
KORU Medical Systems (KRMD) United States $0.115B 0.00
Sensus Healthcare (SRTS) United States $0.098B 20.69
Spectral Diagnostics (EDTXF) Canada $0.098B 0.00
Hyperfine (HYPR) United States $0.087B 0.00
EnVVeno Medical (NVNO) United States $0.075B 0.00
Monogram Orthopaedics (MGRM) United States $0.069B 0.00
InspireMD (NSPR) Israel $0.059B 0.00
Neuronetics (STIM) United States $0.058B 0.00
LENSAR (LNSR) United States $0.056B 0.00
Vicarious Surgical (RBOT) United States $0.046B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Precision Optics (POCI) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.036B 0.00
ReWalk Robotics (LFWD) Israel $0.033B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
Rapid Micro Biosystems (RPID) United States $0.030B 0.00
Autonomix Medical (AMIX) United States $0.027B 0.00
Accelerate Diagnostics (AXDX) United States $0.025B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Aspira Women's Health (AWH) United States $0.021B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
NexGel (NXGL) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00